Sale!

RNF213 Gene Moyamoya Disease Type 2 Susceptibility to Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The RNF213 Gene Moyamoya Disease Type 2 Susceptibility genetic test is a specialized diagnostic tool available at DNA Labs UAE. This test is designed to identify mutations in the RNF213 gene, which have been closely linked to the susceptibility of developing Moyamoya Disease Type 2, a rare, progressive cerebrovascular disorder. The condition is characterized by the narrowing of arteries in the brain, leading to reduced blood flow, potential blood clots, strokes, and transient ischemic attacks (TIAs). Identifying the genetic predisposition to this disease is crucial for early intervention and management strategies.

The test involves a comprehensive analysis of the RNF213 gene to pinpoint specific mutations associated with the disease. This genetic testing is pivotal for individuals with a family history of Moyamoya Disease or those who exhibit symptoms suggestive of this condition, offering them a clear understanding of their risk factors.

Conducted at DNA Labs UAE, a facility renowned for its state-of-the-art genetic testing services, the test ensures accuracy and reliability. The cost of the RNF213 Gene Moyamoya Disease Type 2 Susceptibility genetic test is 4400 AED. The price reflects the sophisticated technology and expertise required to perform this detailed genetic analysis. By opting for this test, individuals gain invaluable insights into their genetic makeup, empowering them with the information needed to make informed health decisions in collaboration with healthcare professionals.

Description

RNF213 Gene Moyamoya Disease Type 2 Susceptibility to Genetic Test

Test Name: RNF213 Gene Moyamoya disease type 2 susceptibility to Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Vascular Diseases

Doctor: General Physician

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for RNF213 Gene Moyamoya disease type 2, susceptibility to NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with RNF213 Gene Moyamoya disease type 2, susceptibility to NGS Genetic DNA Test gene RNF213

Test Details: The RNF213 gene is associated with Moyamoya disease, particularly type 2. Moyamoya disease is a rare cerebrovascular disorder characterized by the progressive narrowing and blockage of the blood vessels in the brain. Type 2 Moyamoya disease is specifically associated with the RNF213 gene. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously. In the case of Moyamoya disease, NGS genetic testing can be used to identify mutations or variations in the RNF213 gene that may increase an individual’s susceptibility to the disease. By analyzing the RNF213 gene using NGS, healthcare professionals can determine if a person carries any genetic variants that may increase their risk of developing Moyamoya disease. This information can be useful for early detection, diagnosis, and management of the condition. It is important to note that genetic testing for Moyamoya disease, including type 2, is typically not recommended for the general population. It is primarily used in cases where there is a family history of the disease or when an individual presents with symptoms suggestive of Moyamoya disease. Genetic counseling is often recommended before and after genetic testing to discuss the implications and limitations of the results.

Test Name	RNF213 Gene Moyamoya disease type 2 susceptibility to Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Vascular Diseases
Doctor	General Physician
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for RNF213 Gene Moyamoya disease type 2, susceptibility to NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with RNF213 Gene Moyamoya disease type 2, susceptibility to NGS Genetic DNA Test gene RNF213
Test Details	The RNF213 gene is associated with Moyamoya disease, particularly type 2. Moyamoya disease is a rare cerebrovascular disorder characterized by the progressive narrowing and blockage of the blood vessels in the brain. Type 2 Moyamoya disease is specifically associated with the RNF213 gene. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously. In the case of Moyamoya disease, NGS genetic testing can be used to identify mutations or variations in the RNF213 gene that may increase an individual’s susceptibility to the disease. By analyzing the RNF213 gene using NGS, healthcare professionals can determine if a person carries any genetic variants that may increase their risk of developing Moyamoya disease. This information can be useful for early detection, diagnosis, and management of the condition. It is important to note that genetic testing for Moyamoya disease, including type 2, is typically not recommended for the general population. It is primarily used in cases where there is a family history of the disease or when an individual presents with symptoms suggestive of Moyamoya disease. Genetic counseling is often recommended before and after genetic testing to discuss the implications and limitations of the results.